Back to UBS Group AG UBS Group AG

MREOMREO
27 quarters

Position history for UBS Group AGUBS Group AG's holdings in MEREO BIOPHARMA GROUP PLC

UBS Group AG holds 1.4M shares of MREO (MEREO BIOPHARMA GROUP PLC), worth $460,346 as of 2026-Q2. The position was decreased (-2.9% shares). MREO represents 0.0% of UBS Group AG's portfolio.

Current Value

$460,346

Current Shares

1.4M

Total Value Change

+$459,346

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.4M
-2.9%
$460,3460.0%$0.32
0
2026-Q1
Decreased
1.5M
-4.4%
$491,7420.0%$0.41
0
2025-Q4
Increased
1.6M
+60.6%
$650,0740.0%$0.37
35
2025-Q3
Increased
970,667
+159.9%
$2M0.0%$1.96
42
2025-Q2
Decreased
373,505
-59.9%
$1M0.0%$2.66
0
2025-Q1
Decreased
932,021
-64.8%
$2.1M0.0%$2.30
0
2024-Q4
New
2.6M
-
$9.3M0.0%$3.52
38
2024-Q1
Exited
0
-100.0%
$00.0%$3.30
0
2023-Q4
New
2,813
-
$6,4980.0%$2.31
24
2023-Q3
Exited
0
-100.0%
$00.0%$1.29
0
2023-Q2
Decreased
2,491
-97.4%
$3,2880.0%$1.27
0
2023-Q1
Decreased
96,157
-25.2%
$67,9830.0%$0.71
0
2022-Q4
Decreased
128,541
-23.3%
$96,4060.0%$0.75
0
2022-Q3
Increased
167,505
+318.8%
$144,0000.0%$0.88
36
2022-Q2
New
40,000
-
$45,0000.0%$1.35
31
2022-Q1
Exited
0
-100.0%
$00.0%$1.04
0
2021-Q4
Increased
23,306
+134.3%
$37,0000.0%$1.61
22
2021-Q3
Increased
9,949
+969.8%
$24,0000.0%$2.40
21
2021-Q2
Decreased
930
-81.8%
$3,0000.0%$3.07
0
2021-Q1
Increased
5,119
+10.3%
$17,0000.0%$3.34
14
2020-Q4
Increased
4,639
+2435.0%
$17,0000.0%$3.55
20
2020-Q3
Decreased
183
-81.0%
$00.0%$2.55
0
2020-Q2
Decreased
965
-47.0%
$2,0000.0%$2.94
0
2020-Q1
Decreased
1,820
-73.9%
$2,0000.0%$0.98
0
2019-Q4
Increased
6,969
+520.0%
$23,0000.0%$2.48
21
2019-Q3
Increased
1,124
+66.3%
$3,0000.0%$3.00
13
2019-Q2
New
676
-
$1,0000.0%$2.52
17

Other major holders of MREO: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used